Product
KITE-585
2 clinical trials
2 indications
Indication
Solid and Hematological MalignanciesIndication
Multiple MyelomaClinical trial
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified CellsStatus: , Estimated PCD: 2040-12-01
Clinical trial
A Phase 1 Multicenter Study of KITE-585, an Autologous Anti-BCMA CAR T-Cell Therapy, in Subjects With Relapsed/Refractory Multiple MyelomaStatus: Terminated, Estimated PCD: 2018-12-17